Patents by Inventor Christian Setz

Christian Setz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS
    Publication number: 20230218614
    Abstract: The present application relates to the use of a phthalazinedione in the prevention or treatment of coronaviral infections. Pharmaceutical compositions, combinations and advantageous formulation techniques are disclosed.
    Type: Application
    Filed: June 9, 2021
    Publication date: July 13, 2023
    Inventors: Wolfgang BRYSCH, Astrid KAISER, Petra SCHULZ, Sara SCHUMANN, Jörg VON WEGERER, Christian SETZ, Ulrich SCHUBERT
  • 6'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL INFECTIONS
    Publication number: 20230165851
    Abstract: The present application relates to 6?-methoxycinchonan-9-ols for use in the prevention or treatment of a coronaviral infection. Pharmaceutical compositions, combinations with antiviral agents, advantageous formulation techniques and a method of treatment are disclosed. Compositions of dietary supplements containing quinine are provided.
    Type: Application
    Filed: April 26, 2021
    Publication date: June 1, 2023
    Inventors: Christian Setz, Ulrich Schubert, Sascha Rheber
  • 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF ACUTE LUNG INJURY
    Publication number: 20230113516
    Abstract: The present invention relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione or one of its pharmaceutically acceptable salts in the prevention or treatment of acute lung injury. The invention in particular relates to the use of 5-amino-2, 3-dihydro-1,4-phthalazinedione sodium salt for said purposes.
    Type: Application
    Filed: March 24, 2021
    Publication date: April 13, 2023
    Inventors: Wolfgang Brysch, Astrid Kaiser, Petra Schulz, Sara Schumann, Jörg von Wegerer, Christian Setz, Ulrich Schubert
  • INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF CORONAVIRAL INFECTIONS
    Publication number: 20230087388
    Abstract: The present application relates to small molecule inhibitors of human deubiquitinases for use in the prevention or treatment of a coronaviral infection. It relates in particular to small molecule inhibitors of USP7 and USP47. Pharmaceutical compositions, respective advantageous formulation techniques and a method of treatment are disclosed.
    Type: Application
    Filed: February 26, 2021
    Publication date: March 23, 2023
    Inventors: Christian Setz, Ulrich Schubert
  • Agents for the treatment of retroviral infectious diseases
    Patent number: 10588896
    Abstract: The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular HIV infections and AIDS, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: March 17, 2020
    Assignee: IMMUNOLOGIK GMBH
    Inventors: Ulrich Schubert, Christian Setz, Wolfgang Brysch, Jörg Von Wegerer
  • AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES
    Publication number: 20170202814
    Abstract: The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular HIV infections and AIDS, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 20, 2017
    Applicant: IMMUNOLOGIK GMBH
    Inventors: Ulrich Schubert, Christian Setz, Wolfgang Brysch, Jörg Von Wegerer